FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

39152007: Erythromycin stearate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
65680013 Erythromycin stearate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
775552014 Erythromycin stearate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
809521000172116 stéarate d'érythromycine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Erythromycin stearate Is a Product containing erythromycin (medicinal product) false Inferred relationship Some
Erythromycin stearate Is a Erythromycin (substance) false Inferred relationship Some
Erythromycin stearate Is a Substance with macrolide structure and antibacterial mechanism of action (substance) true Inferred relationship Some
Erythromycin stearate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Erythromycin (substance) true Inferred relationship Some
Erythromycin stearate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antibacterial (disposition) true Inferred relationship Some
Erythromycin stearate Is a Macrolide (substance) false Inferred relationship Some
Erythromycin stearate Is a Antibacterial false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythromycin stearate Inferred relationship Some
Erythromycin stearate 250mg film tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythromycin stearate Inferred relationship Some
Erythromycin stearate 500mg film tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythromycin stearate Inferred relationship Some
Erythromycin (as erythromycin stearate) 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythromycin stearate Inferred relationship Some
Product containing erythromycin stearate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythromycin stearate Inferred relationship Some
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythromycin stearate Inferred relationship Some 1
Erythromycin (as erythromycin stearate) 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythromycin stearate Inferred relationship Some 1
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Erythromycin stearate Inferred relationship Some 1
Erythromycin (as erythromycin stearate) 500 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Erythromycin stearate Inferred relationship Some 1

This concept is not in any reference sets

Back to Start